New molecular diagnostics business launched in Manchester
The aim of APIS Assay Technologies is to help to realise the clinical and commercial potential of genomic medicine in diagnostic tests and personalisation of treatment.
Read More
Tag: Health Innovation Manchester
NICE, Greater Manchester extend health partnership
A collaboration between Greater Manchester and the National Institute for Health and Care Excellence (NICE) that seeks to improve the health of the local population has been expanded for a further three years.
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
